Lindsey Foulkes
About Lindsey Foulkes
Title and Current Role
Lindsey Foulkes is the Vice President of Corporate Development. In this role, she is responsible for overseeing and guiding the corporate growth and strategic initiatives of the organization. Her work involves identifying and evaluating new business opportunities, leading mergers and acquisitions, and fostering partnerships to drive the company's expansion and market presence.
Education and Expertise
Lindsey Foulkes holds a PhD in Leukaemia Research from the University of Glasgow, showcasing her deep expertise in the field of hematology and oncology. Additionally, she earned a BSc in Immunology from the same institution, equipping her with a strong foundation in the immune system and its various functions. Her academic background underpins her scientific and technical proficiency in the biotechnology and pharmaceutical sectors.
Former Chief Operating Officer at Arecor
Lindsey Foulkes previously served as the Chief Operating Officer of Arecor, a UK AIM-listed, clinical-stage biopharmaceutical company. In this senior management role, she was pivotal in overseeing the company's operations and ensuring its clinical and strategic goals were met. Her leadership contributed to Arecor's progress in the development of innovative therapies.
Career in Commercial and Consulting Roles
Lindsey Foulkes has a diverse career background, with significant experience in senior commercial roles at various organizations. She has worked with Liminal Biosciences, Acambis, and Cangene Corporation, where she was responsible for driving commercial strategies and growth. In addition, she was part of the start-up team for the medical device company, Nexan Ltd. Earlier in her career, she started as a management consultant with McKinsey & Company, providing strategic insights to various clients.
Freelance Consulting in Biotechnology
As a freelance consultant, Lindsey Foulkes has provided specialized business development, strategy, and market analysis support within the biotechnology industry. Her consulting work has primarily focused on oncology and immunology companies, leveraging her in-depth knowledge and expertise to help businesses navigate complex market landscapes and develop effective growth strategies.